Solmic Research GmbH and the European Molecular Biology Laboratory enter into a research collaboration

On December 3, 2018, Posted by , In News, By , With Comments Off on Solmic Research GmbH and the European Molecular Biology Laboratory enter into a research collaboration

Solmic Research GmbH has entered into a research collaboration with the European Molecular Biology Laboratory (EMBL) with the goal to elucidate the mode of action of natural extracts. Natural extracts, such as active ingredients of plants, are the origin of medicine and are widely used for medical applications, especially in…

DKFZ: Defective DNA damage repair leads to chaos in the genome

On November 14, 2018, Posted by , In News, By , , With Comments Off on DKFZ: Defective DNA damage repair leads to chaos in the genome

Scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now found a cause for the frequent catastrophic events in the genetic material of cancer cells that have only been known for a few years: If an important DNA repair system of the cells has failed, this promotes fragmentation…

Sanofi joins Open Targets

On October 31, 2018, Posted by , In News, By , , With Comments Off on Sanofi joins Open Targets

Sanofi has joined Open Targets, the public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation. Public-private collaboration Open Targets announced today that Sanofi has joined its pioneering public-private collaboration to transform drug discovery by improving the success rate for developing new medicines. Sanofi’s expertise…

Immune oncology and beyond at the first joint BioRN and Ci3 Annual Conference

On October 26, 2018, Posted by , In Press Releases, By , , With Comments Off on Immune oncology and beyond at the first joint BioRN and Ci3 Annual Conference

Darmstadt, October 26, 2018 The BioRN Life Science Cluster Rhine-Neckar in Heidelberg and the Cluster for Individualized ImmuneIntervention (Ci3) in Mainz were the organizers of yesterday’s Joint BioRN & Ci3 Annual Conference titled “Immunotherapy and beyond – The next generation of cancer treatment“. 200 participants – members and partners of…

Is it possible to pitch the full potential of discoveries without spilling the secret sauce?

On October 4, 2018, Posted by , In Press Releases, By , , With Comments Off on Is it possible to pitch the full potential of discoveries without spilling the secret sauce?

Heidelberg, 04.10.2018 On Tuesday October 2, Guenter Huhle, Head of JLABS EMEA, Johnson & Johnson Innovation shared key insights on the art of pitching in front of a packed audience of researchers, entrepreneurs and professionals mainly from the Heidelberg area.   Panel discussion: Maciek Drozdz (Principal of Venture Investments for…

Cutting-edge research and social-economic issues of precision oncology at the first Visionary Seminar in Heidelberg

On September 27, 2018, Posted by , In Press Releases, By , , With Comments Off on Cutting-edge research and social-economic issues of precision oncology at the first Visionary Seminar in Heidelberg

Heidelberg, 27.09.2018 On Tuesday September 25, the first Visionary Seminar in Heidelberg focusing on “Precision Oncology”  attracted around 100 participants to learn and discuss about most recent research advancements and cutting-edge technologies in the field, with a focus on their social-economic impact.   Closing panel discussion: Prof. De Nys (Chair…

EUROoC network lays the foundation for joint European organ-on-a-chip research

On September 17, 2018, Posted by , In News, By , , With Comments Off on EUROoC network lays the foundation for joint European organ-on-a-chip research

The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB is coordinating the establishment of a European research network to promote organ-on-a-chip technology. This enables the replication of human organs on a micro scale and is considered a technology with great potential, among other things for the research of new pharmaceutical…

Partnering for Innovation at the Heidelberg Science Day

On September 12, 2018, Posted by , In Press Releases, By , With Comments Off on Partnering for Innovation at the Heidelberg Science Day

Heidelberg, 12.09.2018 To foster innovation and to keep providing cutting-edge science and technology, global healthcare companies are more and more closely collaborating with partners all over the world. The BMBF funded ‘Health Axis Europe Partnering’ (HAEP -) project in which BioRN has the project lead works as interface between innovation…

Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager – based Immunotherapeutics for Multiple Cancer Targets

On August 29, 2018, Posted by , In News, By , , With Comments Off on Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager – based Immunotherapeutics for Multiple Cancer Targets

Affimed will receive $96 million upfront and committed funding and is eligible for up to an additional $5.0 billion including milestone payments, and royalties on sales. Affimed will apply its proprietary Redirected Optimized Cell Killing (ROCK®) platform, which enables the generation of both NK cell and T cell-engaging antibodies, to…

Boehringer Ingelheim Championing Early-Stage Life Science Entrepreneur Innovation in Heidelberg

On July 10, 2018, Posted by , In Press Releases, By ,, , With Comments Off on Boehringer Ingelheim Championing Early-Stage Life Science Entrepreneur Innovation in Heidelberg

Heidelberg 10.07.2018 BioRN as cross-cutting representative of the life science community supported Boehringer Ingelheim in the organisation, promotion and execution of this successful event. Open panel discussion during the Summer Networking Reception. Partnerships with early-stage companies often spark some of the most innovative research and development collaborations in the healthcare…